Rituximab

NORTH CHICAGO, Illinois, July 6, 2026 AbbVie has announced that the European Commission (EC) has granted marketing authorization for...

COPENHAGEN, Denmark, July 6, 2026 Genmab A/S announced that the European Commission (EC) has granted marketing authorization for TEPKINLY®...

COPENHAGEN, Denmark, June 11, 2026 Genmab A/S announced new subgroup analysis results from the pivotal Phase 3 EPCORE FL-1...

SAN DIEGO, California, May 19, 2026 Artiva Biotherapeutics announced multiple data presentations at the upcoming EULAR 2026 Congress highlighting...

LUND, Sweden – May 12, 2026 BioInvent International AB announced that new clinical findings from its ongoing Phase 1/2...